Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Her2-Positive Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00129935
What this trial is testing

EC Followed Docetaxel Versus ET Followed Capecitabine as Adjuvant Chemotherapy for Node Positive Operable Breast Cancer

Who this might be right for
Breast Cancer
Spanish Breast Cancer Research Group 1,384
Testing effectiveness (Phase 2)Study completedNCT05054374
What this trial is testing

Mirdametinib on Its Own or in Combination With Fulvestrant in People With Solid Tumor Cancer

Who this might be right for
Breast CancerBreast Cancer Stage IVHER2-negative Breast Cancer+4 more
Memorial Sloan Kettering Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT02659514
What this trial is testing

Study of Poziotinib in Participants With HER2-Positive Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Spectrum Pharmaceuticals, Inc 67
Testing effectiveness (Phase 2)Study completedNCT01068704
What this trial is testing

Efficacy and Safety of BMS-690514 in Combination With Letrozole to Treat Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Bristol-Myers Squibb 4
Not applicableNo Longer AvailableNCT02142868
What this trial is testing

Expanded Access Study Of Palbociclib (PD-0332991) In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR-Positive, Her2-Negative Advanced Breast Cancer For Whom Letrozole Therapy Is Deemed Appropriate

Who this might be right for
Advanced Breast Cancer (Female)
Pfizer
Not applicableLooking for participantsNCT06281210
What this trial is testing

Vabb After Neoadjuvant Therapy to Avoid Surgery-pCR to Avoid Breast Surgery

Who this might be right for
Breast CancerTriple Negative Breast CancerHER2-positive Breast Cancer+1 more
European Institute of Oncology 77
Not applicableStudy completedNCT04671615
What this trial is testing

Understand the Treatment Patterns and Patients and Their Clinical Outcomes Who Are Taking Palbociclib in a Real Life Setting in Israel.

Who this might be right for
Metastatic Breast Cancer
Pfizer 559
Large-scale testing (Phase 3)Active Not RecruitingNCT05802225
What this trial is testing

Clinical Study of the Efficacy and Safety of BCD-178 and Perjeta® as Neoadjuvant Therapy of HER2-Positive Breast Cancer

Who this might be right for
Breast Cancer
Biocad 398
Testing effectiveness (Phase 2)Ended earlyNCT00810017
What this trial is testing

Phase 2 Study of Trastuzumab and Etoposide for Her2 Positive Breast Cancer

Who this might be right for
HER-2 Positive Metastatic Breast Cancer
Medstar Health Research Institute 2
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06973525
What this trial is testing

This Study Aims to Optimize Neoadjuvant Therapy for HER2-positive Breast Cancer by Implementing a Dynamic Monitoring-guided Treatment Strategy.

Who this might be right for
HER2-positive Breast Cancer
Hebei Medical University Fourth Hospital 30
Not applicableStudy completedNCT04850625
What this trial is testing

Pyrotinib Plus Vinorelbine Versus Lapatinib Plus Capecitabine

Who this might be right for
Breast Cancer
Fudan University 224
Large-scale testing (Phase 3)Not Yet RecruitingNCT07748260
What this trial is testing

De-escalation Neoadjuvant Therapy for Intermediate Risk HER2-positive Early Breast

Who this might be right for
HER2-positive Breast Cancer
Guangdong Provincial People's Hospital 592
Early research (Phase 1)Active Not RecruitingNCT04288089
What this trial is testing

H3B-6545 in Combination With Palbociclib in Women With Advanced or Metastatic Estrogen Receptor-Positive Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer

Who this might be right for
Receptors, EstrogenGenes, Erbb-2Breast Neoplasms
Eisai Inc. 31
Not applicableUnknownNCT03847818
What this trial is testing

Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Chemotherapy in Patients With HER2 Positive Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Shandong University 268
Not applicableStudy completedNCT02632435
What this trial is testing

Randomized Trial Standard of Care Vascular Access Strategies for (Neo)Adjuvant Trastuzumab-based Breast Cancer Treatment.

Who this might be right for
Breast CancerCancer
Ottawa Hospital Research Institute 56
Testing effectiveness (Phase 2)Study completedNCT05963997
What this trial is testing

Samuraciclib and Elacestrant in Participants With Metastatic or Locally Advanced HR+/HER2-negative Breast Cancer

Who this might be right for
Metastatic Breast CancerLocally Advanced Breast CancerBreast Cancer
Carrick Therapeutics Limited 49
Early research (Phase 1)Study completedNCT01097460
What this trial is testing

MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cancer

Who this might be right for
Breast Neoplasms
Merrimack Pharmaceuticals 16
Not applicableUnknownNCT06479460
What this trial is testing

Clinical Application of ctDNA Dynamic Monitoring in Neoadjuvant Therapy for HER2-positive Breast Cancer Patients

Who this might be right for
Breast CancerNeoadjuvantHER2-positive Breast Cancer+1 more
The First Affiliated Hospital with Nanjing Medical University 50
Large-scale testing (Phase 3)Looking for participantsNCT06891833
What this trial is testing

BL-M07D1 With or Without Pertuzumab Versus Docetaxel + Carboplatin + Trastuzumab + Pertuzumab in Neoadjuvant Therapy for HER2-Positive Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 985
Testing effectiveness (Phase 2)Active Not RecruitingNCT06008158
What this trial is testing

Evaluation of a Once Per Day Regimen of Accelerated Partial Breast Irradiation for Improved Breast Appearance in Pts w/Low Risk, Hormone Responsive Brst Ca

Who this might be right for
Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Estrogen Receptor-Positive Breast Carcinoma+1 more
City of Hope Medical Center 48
Next Page